№ lp_1_2_23785
File format: docx
Character count: 13151
File size: 45 KB
This document lists a range of mortgage instruments, including state-specific forms and riders, available for use by sellers and servicers delivering mortgages to Freddie Mac.
Year:
2021
Region / City:
United States
Theme:
Mortgage Instruments, Real Estate
Document Type:
Official Document
Organization / Institution:
Freddie Mac
Author:
Freddie Mac
Target Audience:
Sellers/Servicers, Mortgage Originators
Period of Validity:
Ongoing
Approval Date:
July 2021
Date of Changes:
Various (multiple revisions listed)
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
United States
Topic:
Mortgage Document Changes
Document Type:
Guideline
Organization / Institution:
Freddie Mac
Author:
Freddie Mac
Target Audience:
Mortgage Originators
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
2026
Type of Instrument:
Mortgage Note
Instrument Revision Date:
05/2024
State:
FL
Lien Type:
First
Product Type:
ARM – Plan 4926
Property Type:
All, except cooperatives
Occupancy Type:
All
Authorized Changes:
Lenders may add initial lines for borrowers on each page, adjust cross-references, or add a disclosure notice if required by law.
Other Pertinent Information:
Special instructions for inter vivos revocable trusts and signature forms.
Year:
2014
Region / City:
All States
Subject:
Loan Modification Agreement
Document Type:
Legal Agreement
Author:
Fannie Mae
Target Audience:
Lenders, Borrowers
Effective Period:
Ongoing
Approval Date:
1/01 (rev. 4/14)
Modification Date:
6/06 (posted 10/3/06)
Context:
A detailed legal document outlining the requirements and amendments for modifying a loan agreement in accordance with various conditions and government programs.
Instrument Type:
Mortgage
Form Number:
3054
Instrument Revision Date:
07/2021
Jurisdiction:
U.S. Virgin Islands
Property Type:
Single-family residential property
Lien Type:
First lien
Applicable Programs:
Fannie Mae, Freddie Mac
Occupancy Type:
All
Exclusions:
Cooperative properties
Governing Law Reference:
Truth in Lending Act; Regulation Z (12 C.F.R. § 1026.36(g))
Authorized Modifications:
Required and optional lender changes
Use Context:
Mortgage loan origination and recordation
Document Status:
Uniform instrument
Jurisdiction:
New Mexico, United States
Program:
Single-Family Homeownership Programs
Type of document:
Mortgage purchase master agreement
Status:
Sample document for review only
Parties:
New Mexico Mortgage Finance Authority; approved mortgage lenders
Subject matter:
Purchase of eligible mortgage loans
Governing authority:
New Mexico Mortgage Finance Authority
Applicable law:
Internal Revenue Code of 1986, as amended
Related documents:
Program Documents; Mortgage Purchase Contract
Purpose:
Authorization and conditions for the sale of eligible mortgage loans
Type of Instrument:
Rider
Instrument Revision Date:
07/2021
Instrument Last Modified:
11/21 (Required change 1 revised)
State:
Montana, Oregon, Washington
Lien Type:
First
Product Type:
All
Property Type:
All, except cooperatives
Occupancy Type:
All
Required Changes:
Lenders may use this rider to name MERS as the nominee for the lender in the security instrument in the states listed above.
Authorized Changes:
Lenders may include “initial lines” on each page for borrowers to acknowledge receipt of all pages. Lenders may adjust cross-references as needed.
Other Pertinent Information:
Special instructions for inter vivos revocable trusts, including signature requirements for trustees.
Year:
2026
Region / City:
Not specified
Topic:
Water System Capacity Evaluation
Document Type:
Technical Report
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Engineers, water system planners
Effective Period:
Not specified
Approval Date:
Not specified
Revision Date:
Not specified
Note:
Contextual Description
Type of Instrument:
Mortgage Note
Instrument Revision Date:
05/2024
State:
FL
Lien Type:
First
Product Type:
ARM – Plan 4926
Property Type:
All, except cooperatives
Occupancy Type:
All
Authorized Changes:
Lenders may add initial lines for borrowers on each page, adjust cross-references, or add a disclosure notice if required by law.
Other Pertinent Information:
Special instructions for inter vivos revocable trusts and signature forms.
Year:
2025
Region / City:
Indianapolis
Theme:
Residential construction
Document type:
Request for Proposal (RFP)
Organization / Institution:
Indianapolis Neighborhood Housing Partnership
Author:
Not specified
Target audience:
Residential general contractors
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Contractor responsibilities:
Detailed scope of work, labor, and material pricing
Subcontractor requirements:
Must provide a list of sub-contractors
Additional requirements:
XBE participation and reporting, use of certified subcontractors
Inspection availability:
Upon request to the INHP Construction Project Manager
Note:
Year
Year:
2021
Jurisdiction:
Multistate (excluding PR & WV, Texas Section 50(a)(6))
Document Type:
Mortgage Rider
Related Instrument:
Fannie Mae/Freddie Mac Uniform Instrument (Form 3142)
Revision Date:
07/2021
Last Modified:
05/24
Applicable Products:
ARM Plans 4927, 4928, 4929
Property Type:
Single-Family
Occupancy Type:
All
Required Changes:
None
Authorized Changes:
Initial lines for borrower acknowledgment, cross-reference adjustments
Trustee Requirements:
Signatures for inter vivos revocable trusts, special signature forms if applicable
Printing Instructions:
Letter size, portrait format
Year:
2026
Region / City:
N/A
Topic:
Consultant Contract DBE Information
Document Type:
Form
Institution / Organization:
Caltrans
Author:
N/A
Target Audience:
Consultants, Local Agencies, Caltrans
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Note:
Course Number and Title
Year:
2021
Region / City:
European Union
Subject:
Animal health, bovine semen, intra-community trade
Document Type:
Model Certificate
Organization:
Department of Agriculture, Environment and Rural Affairs (DAERA)
Author:
NA
Target Audience:
Certifying official veterinarians (aPVP), operators of bovine semen storage centres
Period of validity:
From 20 April 2021
Approval Date:
20 April 2021
Amendment Date:
NA
Document type:
Compliance certificate
Form designation:
FORM D1
Stock exchange:
JSE Limited
Applicable listings:
Primary listing; Secondary listing; Interest Rate Market instruments
Regulatory framework:
JSE Listings Requirements; Debt Listings Requirements
Reporting period:
Twelve months ended at the relevant financial year-end
Issuing authority:
JSE Limited
Signatory requirement:
Duly authorised representative on behalf of the directors
Corporate bodies referenced:
Board of directors; Audit committee
Purpose:
Certification of compliance with listing, disclosure, and statutory requirements
Context:
Standardised regulatory source text used by issuers to formally attest compliance with stock exchange obligations during a defined financial period.
Note:
Year
Subject:
Medicine Formularies, Health Policy
Document Type:
Form, Application
Institution:
Ministry of Health
Author:
Applicant (Consultant, Specialist, Medical Officer, Pharmacist)
Target Audience:
Healthcare Professionals, Drug and Therapeutic Committee
Context:
Form used to propose the inclusion of a medicine or indication from the Ministry of Health Medicines Formulary into an institution’s Medicines Formulary for approval by the institution’s Drug and Therapeutic Committee.